These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20081743)

  • 1. Tissue-engineered heart valve scaffolds.
    Dohmen PM; Konertz W
    Ann Thorac Cardiovasc Surg; 2009 Dec; 15(6):362-7. PubMed ID: 20081743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical results of implanted tissue engineered heart valves.
    Dohmen PM
    HSR Proc Intensive Care Cardiovasc Anesth; 2012; 4(4):225-31. PubMed ID: 23439388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cells, scaffolds and bioreactors for tissue-engineered heart valves: a journey from basic concepts to contemporary developmental innovations.
    Gandaglia A; Bagno A; Naso F; Spina M; Gerosa G
    Eur J Cardiothorac Surg; 2011 Apr; 39(4):523-31. PubMed ID: 21163670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue engineering of heart valves: advances and current challenges.
    Mol A; Smits AI; Bouten CV; Baaijens FP
    Expert Rev Med Devices; 2009 May; 6(3):259-75. PubMed ID: 19419284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: Tissue engineering of semilunar heart valves: current status and future developments.
    Mol A; Bouten CV; Baaijens FP; Zünd G; Turina MI; Hoerstrup SP
    J Heart Valve Dis; 2004 Mar; 13(2):272-80. PubMed ID: 15086267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining tissue repair and tissue engineering; bioactivating implantable cell-free vascular scaffolds.
    Muylaert DE; Fledderus JO; Bouten CV; Dankers PY; Verhaar MC
    Heart; 2014 Dec; 100(23):1825-30. PubMed ID: 25053725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable living marrow stromal cell-based autologous tissue engineered heart valves: first experiences with a one-step intervention in primates.
    Weber B; Scherman J; Emmert MY; Gruenenfelder J; Verbeek R; Bracher M; Black M; Kortsmit J; Franz T; Schoenauer R; Baumgartner L; Brokopp C; Agarkova I; Wolint P; Zund G; Falk V; Zilla P; Hoerstrup SP
    Eur Heart J; 2011 Nov; 32(22):2830-40. PubMed ID: 21415068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart valve engineering: decellularized allograft matrices in clinical practice.
    Neumann A; Cebotari S; Tudorache I; Haverich A; Sarikouch S
    Biomed Tech (Berl); 2013 Oct; 58(5):453-6. PubMed ID: 23729596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioengineering strategies for polymeric scaffold for tissue engineering an aortic heart valve: an update.
    Morsi YS
    Int J Artif Organs; 2014 Sep; 37(9):651-67. PubMed ID: 25262629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart valve tissue engineering.
    Neuenschwander S; Hoerstrup SP
    Transpl Immunol; 2004 Apr; 12(3-4):359-65. PubMed ID: 15157927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From stem cells to viable autologous semilunar heart valve.
    Sutherland FW; Perry TE; Yu Y; Sherwood MC; Rabkin E; Masuda Y; Garcia GA; McLellan DL; Engelmayr GC; Sacks MS; Schoen FJ; Mayer JE
    Circulation; 2005 May; 111(21):2783-91. PubMed ID: 15927990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durability of tissue valves.
    Chikwe J; Filsoufi F
    Semin Thorac Cardiovasc Surg; 2011; 23(1):18-23. PubMed ID: 21807294
    [No Abstract]   [Full Text] [Related]  

  • 13. Morphologic findings in explanted Hancock II porcine bioprostheses.
    Butany J; Yu W; Silver MD; David TE
    J Heart Valve Dis; 1999 Jan; 8(1):4-15. PubMed ID: 10096476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of tissue engineered human heart valves using autologous progenitor cells.
    Cebotari S; Lichtenberg A; Tudorache I; Hilfiker A; Mertsching H; Leyh R; Breymann T; Kallenbach K; Maniuc L; Batrinac A; Repin O; Maliga O; Ciubotaru A; Haverich A
    Circulation; 2006 Jul; 114(1 Suppl):I132-7. PubMed ID: 16820562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpreting a 20-year experience with the Biocor porcine bioprosthesis.
    Suyker WJ; Leicher FG
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1354-5. PubMed ID: 20412969
    [No Abstract]   [Full Text] [Related]  

  • 16. Human or animal homograft: could they have a future as a biological scaffold for engineered heart valves?
    Dainese L; Biglioli P
    J Cardiovasc Surg (Torino); 2010 Jun; 51(3):449-56. PubMed ID: 20523298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current developments in the tissue engineering of autologous heart valves: moving towards clinical use.
    Apte SS; Paul A; Prakash S; Shum-Tim D
    Future Cardiol; 2011 Jan; 7(1):77-97. PubMed ID: 21174513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The "ideal" replacement heart valve.
    Sapirstein JS; Smith PK
    Am Heart J; 2001 May; 141(5):856-60. PubMed ID: 11320378
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of an in vivo tissue-engineered, autologous heart valve (the biovalve): preparation of a prototype model.
    Hayashida K; Kanda K; Yaku H; Ando J; Nakayama Y
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):152-9. PubMed ID: 17599501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trans-apical versus surgical implantation of autologous ovine tissue-engineered heart valves.
    Dijkman PE; Driessen-Mol A; de Heer LM; Kluin J; van Herwerden LA; Odermatt B; Baaijens FP; Hoerstrup SP
    J Heart Valve Dis; 2012 Sep; 21(5):670-8. PubMed ID: 23167234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.